AUTHOR=Hanna Stephanie J. , Thayer Terri C. , Robinson Emma J. S. , Vinh Ngoc-Nga , Williams Nigel , Landry Laurie G. , Andrews Robert , Siah Qi Zhuang , Leete Pia , Wyatt Rebecca , McAteer Martina A. , Nakayama Maki , Wong F. Susan , Yang Jennie H. M. , Tree Timothy I. M. , Ludvigsson Johnny , Dayan Colin M. , Tatovic Danijela TITLE=Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans JOURNAL=Frontiers in Immunology VOLUME=14 YEAR=2023 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1276255 DOI=10.3389/fimmu.2023.1276255 ISSN=1664-3224 ABSTRACT=
Gold nanoparticles (GNPs) have been used in the development of novel therapies as a way of delivery of both stimulatory and tolerogenic peptide cargoes. Here we report that intradermal injection of GNPs loaded with the proinsulin peptide C19-A3, in patients with type 1 diabetes, results in recruitment and retention of immune cells in the skin. These include large numbers of clonally expanded T-cells sharing the same paired T-cell receptors (TCRs) with activated phenotypes, half of which, when the TCRs were re-expressed in a cell-based system, were confirmed to be specific for either GNP or proinsulin. All the identified gold-specific clones were CD8+, whilst proinsulin-specific clones were both CD8+ and CD4+. Proinsulin-specific CD8+ clones had a distinctive cytotoxic phenotype with overexpression of granulysin (GNLY) and KIR receptors. Clonally expanded antigen-specific T cells remained